|
Carolyn F. Pedley, M.D. |
|
Associate Professor
|
Office Address:
Section of General Internal Medicine
Wake Forest University, School of Medicine
Medical Center Boulevard
Winston-Salem, North Carolina 27157-1052
Clinic Location: Downtown Health Plaza
Office: (336) 713-9800
Nights: (336) 713-9800
Fax: (336) 713-9576
click here for a PDF version of Dr. Pedley's CV
|
|
|
|
Education |
|
1973 |
Duke University
Durham, North Carolina
B.A. Chemistry |
|
1977 |
Duke University Medical School
Durham, North Carolina
M.D. |
|
POSTDOCTORAL TRAINING |
|
1977-1978 |
Internship
Department of Internal Medicine
Bowman Gray School of Medicine
North Carolina Baptist Hospital
Winston-Salem, North Carolina |
|
1979-1980 |
Residency
Department of Internal Medicine
Bowman Gray School of Medicine
North Carolina Baptist Hospital
Winston-Salem, North Carolina |
|
PROFESSIONAL LICENSURE |
|
1979 |
North Carolina State Medical License |
|
1979 |
National Board of Medical Examiners |
|
SPECIALTY CERTIFICATION |
|
1982 |
American Board of Internal Medicine |
|
ACADEMIC APPOINTMENTS |
|
1982 - 1989 |
Instructor
Department of Internal Medicine
Bowman Gray School of Medicine
Winston-Salem, NC |
|
1985 - Present |
Medical Director
Diabetic Clinic
Reynolds Health Center
Winston-Salem, NC |
|
1989 - Present |
Assistant Professor
Department of Internal Medicine
Bowman Gray School of Medicine
Winston-Salem, NC |
|
1998 - Present |
Director
Specialty Clinics
Reynolds Health Center
Winston-Salem, NC |
|
EMPLOYMENT |
|
1978 |
Public Health Service
Indian Health Service Branch
Navajo Reservation
Kayenta, Arizona |
|
1980 - 1981 |
Emergency Room Physician
North Wilkesboro, NC |
|
1980 - 1981 |
S.T.D. Clinic
Health Department
Lexington, NC |
|
1981 |
Outpatient Medicine
Cleveland Clinic
Cleveland, NC |
|
1981 - 1983 |
Outpatient Medicine
Winston-Salem Health Care
Winston-Salem, NC |
|
1982 - Present |
S.T.D. Clinic
Reynolds Health Center
Winston-Salem, NC |
|
1993 - Present |
Medical Director
Atherosclerosis Risk In
Communities Project, NIH |
|
PROFESSIONAL MEMBERSHIPS |
|
|
American College of Physicians |
|
|
N.C. Medical Society |
|
|
Forsyth County Medical Society |
|
|
American Diabetes Association |
|
HONORS AND AWARDS |
|
1973 |
Phi Beta Kappa
Magna Cum Laude
Duke University
Durham, NC |
|
1977 |
Honors in: Infectious Diseases,
Renal and Neurology rotations
Duke University School of Medicine
Durham, NC |
|
Publications |
|
BOOKS: |
|
Bloomfield RL, Pedley CF. Mnemonics, rhetoric and poetics for medics. Vol II, all new. Winston-Salem, NC: Harbinger Medical Press, 1984. |
|
Bloomfield RL, Pedley CF. Mnemonics, rhetoric and poetics for medics. Vol III. Winston-Salem, NC: Harbinger Medical Press, 1989 |
|
Bloomfield RL, Pedley CF. Cardiovascular mnemonics. Charlottesville, Va. And Winston-Salem, NC. Harbinger Medical Press, 1990. |
|
Bloomfield RL, Cefalu WT, Pedley CF. Hypertension Textbook. Chapter 6 The Endocrinologist Viewpoint, Carolina Academic Press, Durham, NC. 1995. |
|
JOURNAL ARTICLES: |
|
Bloomfield RL, Pedley CF. Mnemonics for board review. Resident Staff Physician 1988. |
|
Bloomfield RL, Weavil PD, Pedley CF. Papilledema: the three I's of optic disc edema. Resident Staff Physician 1989:35. 105-113. |
|
Pedley CF, Bloomfield RL. Clarifying the view. Consultant 1990:30(3). 285. |
|
Pedley CF, Bloomfield RL. A simplified approach to proteinuria. Medical Times 1990:118(1). 17-23. |
|
Pedley CF, Bloomfield RL. A simplified approach to proteinuria. Resident & Staff Physician 1991:37(3). 61-65. |
|
Bloomfield RL, Pedley CF, Greven C, Callahan M, Zurek G. Nonproliferative diabetic retinopathy does not predict proteinuria. JASN 1991:2(3). 285 |
|
Pedley CF, Bloomfield RL. Mortality associated with diuretic therapy in diabetes mellitus. ACP Journal Club 1991:vol.#:93. |
|
Pedley CF, Bloomfield RL. Screening for Noninsulin-Dependent Diabetes Mellitus in Older Adults. ACP Journal Club 1992:116.suppl. 3:83. |
|
Pedley CF, Bloomfield RL. Aspirin for Diabetic Retinopathy. ACP Journal Club 1992:vol.#:I 16.suppl. 2:49. |
|
Pedley CF, Bloomfield RL. Hypertension in Diabetes. Consultant 1992:32(9). 108-118. |
|
Pedley CF, Bloomfield RL, Colflesh Md, Porcel M, Novikov SV. Purpura and ecchymoses from a blood pressure monitor. American JL Hypertens. Nov.1994. |
|
LETTERS: |
|
Bloomfield RL, Miller HJ, Noikov S, Pedley CF, Colflesh MJ. Using calcium channel blockers in hypertensive patients; a historical perspective. Arch Int Med. May 1996 (Letter) |
|
Bloomfield RL, Pedley CF, Leonard M. Letter to the Editor. Refers to: Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudo-emergencies? JAMA 1997: 277(10). 788. |
|
ABSTRACTS: |
|
Bloomfield RL, Wilson DJ, Hansen CJ, Pedley CF, Zurck G. Effect of triamterene on potassium and blood pressure in hypertensive subjects with thiazide induced hypokalemia. In Program and Abstracts: Second Annual Meeting of the American Society of Hypertension: Second World Congress on Biologically Active Atrial Peptides. (Winston-Salem, NC): Harbinger Medical, 1988:130. |
|
Pedley CF, Bloomfield RL, Young L, Graves J. Patient awareness of diabetes mellitus as a factor in the progression of heart disease. J Am Diabetes Assoc 1989:38(2). 173A. |
|
Bloomfield RL, Canzanello VJ, Pedley CF, Grogan, Zurek G, Bearden BS. Ambulatory Blood Pressure Monitoring in Diabetics: Correlations with Microalbuminuria, Retinopathy and Glyccmic control. American Journal of Hypertension 1992. 5(5). Part 2:80A. |
|
RESEARCH: |
|
1985 |
Co-Investigator
In a comparative multicenter evaluation of Cefadroxil and Amoxicillin therapy in the treatment of uncomplicated urinary tract infections.
Funded by Bristol-Myers |
|
1985 - 1986 |
Co-Investigator
A post marketing study into the efficacy and safety of Cardizem (Diltiazen HCI).
Funded by Marion Laboratories |
|
1986 |
Co-Investigator
The effect of the interactions of nonsteroidal anti-inflammatory agents (NSAID) and angiotensin converting enzyme (ACE) inhibition on blood pressure and renal function in diabetic patients with hypertension.
Funded by Merck Sharp and Dohme |
|
1987 - 1988 |
Primary Investigator
In the use of Captopril in the treatment of diabetic hypertensice patients.
Funded by E.R. Squibb, Inc. |
|
1989 |
Co-Investigator
Investigation of the lipid-lowering Capabilities of Lopid in diabetic patients.
Funded by Marion Merrill DOW, Inc. |
|
1990 - 1996 |
Co-Investigator
The safety and efficacy of Tolrestat in prevention of nephropathy in insulin-dependant diabetics with microalbuminuria.
Funded by Wyeth-Ayerst Pharmaceutical Company |
|
1990 - 1995 |
Primary Investigator
The safety and efficacy of Tolrestat in mild non-proliferative retinopathy in non-insulin
dependent diabetes.
Funded by Wyeth-Ayerst Pharmaceutical Company |
|
1992 - 1993 |
Co-Investigator
Evaluation of the Efficacy and Safety, Glimepiride Vs. Glyburide in Subjects With NIDDM.
Funded by UpJohn, Inc - merged with Pharmacia, Inc |
|
1992 - 1993 |
Primary Investigator
Changes in Knowledge and Skills In a Population of Diabetics, Following an Eight Week Course of Diabetic Education Classes.
Funded by Forsyth County Health Dept./ Reynolds Health Center |
|
1993 - 1994 |
Co-Investigator
Racial Differences in Microalbuminuria in Type II Diabetes Mellitus
Partial Funded By Support - Bristol-Myers, Squibb |
|
1993 - 1995 |
Primary Investigator
Screening for Diabetic Eye Disease Using Retinal Photography.
Funded by Kate B. Reynolds Foundation |
|
1994 - 1995 |
Primary Investigator
Treatment of Diabetic Microalbumin with Cardizem (vs. Capoten, Cardura);
Evaluation of Treatment in a Randomized Protocol.
Funded by The Methodist Hospital of Indiana, Pfizer |
|
1994 - 1995 |
Co-Investigator
A Program to Increase Self Efficacy, Knowledge, Skills, and Glycemic Control In Patients with Diabetes Mellitus.
Funded by Reynolds Health Center - renamed Downtown Health Plaza |
|
1995 - Present |
Co-Investigator
The Family Heart Study.
NIH |
|
1996 - 1999 |
Primary Investigator
Comprehensive Diabetics Program.
Funded by Kate B. Reynolds Poor & Needy Trust
Reynolds Health Center - renamed Downtown Health Plaza |
|
|
|